184 related articles for article (PubMed ID: 22507966)
21. Acinic cell carcinoma of the parotid gland: review and management.
Spafford PD; Mintz DR; Hay J
J Otolaryngol; 1991 Aug; 20(4):262-6. PubMed ID: 1920580
[TBL] [Abstract][Full Text] [Related]
22. [Acinic cell carcinomas of the parotid gland. A retrospective analysis].
Federspil PA; Constantinidis J; Karapantzos I; Pahl S; Markmann HU; Iro H
HNO; 2001 Oct; 49(10):825-30. PubMed ID: 11699143
[TBL] [Abstract][Full Text] [Related]
23. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
[TBL] [Abstract][Full Text] [Related]
24. Metastatic cutaneous squamous cell carcinoma to parotid nodes: the role of bolus with adjuvant radiotherapy.
Pramana A; Browne L; Graham PH
J Med Imaging Radiat Oncol; 2012 Feb; 56(1):100-8. PubMed ID: 22339753
[TBL] [Abstract][Full Text] [Related]
25. Conservative parotidectomy for the treatment of parotid cancers.
Lim YC; Lee SY; Kim K; Lee JS; Koo BS; Shin HA; Choi EC
Oral Oncol; 2005 Nov; 41(10):1021-7. PubMed ID: 16129655
[TBL] [Abstract][Full Text] [Related]
26. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
27. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiation therapy for small, low-/intermediate-grade parotid tumors with close and/or positive surgical margins.
Richter SM; Friedmann P; Mourad WF; Hu KS; Persky MS; Harrison LB
Head Neck; 2012 Jul; 34(7):953-5. PubMed ID: 21850698
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors depicting disease-specific survival in parotid-gland tumors.
Koul R; Dubey A; Butler J; Cooke AL; Abdoh A; Nason R
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):714-8. PubMed ID: 17398019
[TBL] [Abstract][Full Text] [Related]
30. [Clinical analysis of sixteen cases of lymphoepithelial carcinoma of salivary gland].
Zhang Q; Qing J; Wei MW; Guo ZM
Ai Zheng; 2005 Nov; 24(11):1384-7. PubMed ID: 16552968
[TBL] [Abstract][Full Text] [Related]
31. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
Sklenicka S; Gardiner S; Dierks EJ; Potter BE; Bell RB
J Oral Maxillofac Surg; 2010 Jun; 68(6):1270-5. PubMed ID: 20347201
[TBL] [Abstract][Full Text] [Related]
32. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.
Cederblad L; Johansson S; Enblad G; Engström M; Blomquist E
Acta Oncol; 2009; 48(4):549-55. PubMed ID: 19140053
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
Stessin AM; Meyer JE; Sherr DL
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
[TBL] [Abstract][Full Text] [Related]
34. Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Vern-Gross TZ; Shivnani AT; Chen K; Lee CM; Tward JD; MacDonald OK; Crane CH; Talamonti MS; Munoz LL; Small W
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):189-98. PubMed ID: 20971573
[TBL] [Abstract][Full Text] [Related]
35. Synchronous bilateral acinic cell carcinoma of the parotid: when a tumor reveals another one.
Durand N; Mourrain-Langlois E; Leclair F; Malard O
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Feb; 130(1):22-5. PubMed ID: 23017274
[TBL] [Abstract][Full Text] [Related]
36. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the role of radiation therapy in the management of malignant thymoma.
Patel S; Macdonald OK; Nagda S; Bittner N; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1797-801. PubMed ID: 21596484
[TBL] [Abstract][Full Text] [Related]
38. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group.
Terhaard CH; Lubsen H; Van der Tweel I; Hilgers FJ; Eijkenboom WM; Marres HA; Tjho-Heslinga RE; de Jong JM; Roodenburg JL;
Head Neck; 2004 Aug; 26(8):681-92; discussion 692-3. PubMed ID: 15287035
[TBL] [Abstract][Full Text] [Related]
39. Head & neck acinar cell carcinoma: a population-based study using the seer registry.
Yibulayin F; Feng L; Wang M; Lu MM; Luo Y; Liu H; Yang ZC; Wushou A
BMC Cancer; 2020 Jul; 20(1):631. PubMed ID: 32641007
[TBL] [Abstract][Full Text] [Related]
40. Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases.
Patel NR; Sanghvi S; Khan MN; Husain Q; Baredes S; Eloy JA
Laryngoscope; 2014 Jan; 124(1):172-8. PubMed ID: 23754708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
